Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001104659-24-082673
Filing Date
2024-07-25
Accepted
2024-07-25 16:48:54
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM F-10 tm2419848d1_f10.htm F-10 173983
2 EXHIBIT 5.1 tm2419848d1_ex5-1.htm EX-5.1 3252
3 EX-FILING FEES tm2419848d1_ex-filingfees.htm EX-FILING FEES 15542
4 GRAPHIC tm2419848d1_f10img001.jpg GRAPHIC 9152
5 GRAPHIC tm2419848d1_f10img002.jpg GRAPHIC 9163
  Complete submission text file 0001104659-24-082673.txt   219290
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-281009 | Film No.: 241142635
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)